Comparison of three different chemotherapy regimens for concomitant chemoradiotherapy in locally advanced non-small cell lung cancer Nadiye AkdenizMehmet KüçükönerPerran Fulden Yumuk Original Article 14 August 2020 Pages: 2015 - 2024
High expression of microRNA20b is associated with malignant clinicopathological features and poor prognosis in breast phyllodes tumor Ting LeiLijuan YinHong Bu Original Article 16 August 2020 Pages: 2025 - 2034
A phase II trial of dose-reduced nab-paclitaxel for patients with previously treated, advanced or recurrent gastric cancer (OGSG 1302) Shigeyuki TamuraHirokazu TaniguchiTaroh Satoh Original Article Open access 14 September 2020 Pages: 2035 - 2043
HOXC9 overexpression is associated with gastric cancer progression and a prognostic marker for poor survival in gastric cancer patients Xue-Feng ZhaoYu-Shen YangYoung Kyu Park Original Article 20 August 2020 Pages: 2044 - 2054
YAP promotes self-renewal of gastric cancer cells by inhibiting expression of L-PTGDS and PTGDR2 Qingli BieXiaozhe LiBin Zhang Original Article 26 August 2020 Pages: 2055 - 2065
FLOX (5-fluorouracil + leucovorin + oxaliplatin) chemotherapy for colorectal cancer leads to long-term orofacial neurotoxicity: a STROBE-guided longitudinal prospective study Priscilla de Albuquerque Ribeiro GondinhoPaulo Goberlânio de Barros SilvaMariana Lima Vale Original Article 06 August 2020 Pages: 2066 - 2074
Oxaliplatin-induced increase in splenic volume: experiences from multicenter study in Japan Ryo OhtaTakeshi YamadaHideyuki Ishida Original Article 12 August 2020 Pages: 2075 - 2082
Effectiveness of repeat surgery for recurrence after primary hepatectomy in patients with intrahepatic cholangiocarcinoma Kazunori TokudaYuji MorineMitsuo Shimada Original Article 31 August 2020 Pages: 2083 - 2089
Health-related quality of life in Japanese patients with bladder cancer measured by a newly developed Japanese version of the Bladder Cancer Index Takahiro OsawaJohn T. WeiNobuo Shinohara Original Article Open access 24 August 2020 Pages: 2090 - 2098
Optimal treatment strategy for paratesticular liposarcoma: retrospective analysis of 265 reported cases Rei KamitaniKazuhiro MatsumotoMototsugu Oya Original Article 26 July 2020 Pages: 2099 - 2106
The impact of complications after initial prostate biopsy on repeat protocol biopsy acceptance rate. Results from the Prostate Cancer Research International: Active Surveillance JAPAN study Yoichiro TohiTakuma KatoMikio Sugimoto Original Article 08 August 2020 Pages: 2107 - 2114
Positive node burden rather than the number of removed nodes impacts survival in patients with node-positive prostate cancer Xiao-xiao GuoRun-qi GuoMing Liu Original Article 03 August 2020 Pages: 2115 - 2121
Effect of general self-efficacy on promoting health-related quality of life during recovery from radical prostatectomy: a 1-year prospective study Kansuke KawaguchiHisashi KawazoeWakako Sato Original Article 14 August 2020 Pages: 2122 - 2129
Effect of core needle biopsy number on intraductal carcinoma of the prostate (IDC-P) diagnosis in patients with metastatic hormone-sensitive prostate cancer Masashi KatoAkihiro HirakawaToyonori Tsuzuki Original Article 03 August 2020 Pages: 2130 - 2137
Diagnostic criteria of sentinel lymph node micrometastasis or macrometastasis based on tissue rinse liquid-based cytology in gynecological cancer Hiroko MatsumiyaYukiharu TodoKatsushige Yamashiro Original Article 26 August 2020 Pages: 2138 - 2143
Clinicopathologic and survival analysis of patients with adenoid cystic carcinoma of vulva: single-institution experience Jun ZhuLina YinGuihao Ke Original Article 10 August 2020 Pages: 2144 - 2150
Daratumumab therapy for relapsed or refractory multiple myeloma: a single-center retrospective study Kazutaka SunamiHiroyuki MurakamiMasanori Makita Original Article 26 July 2020 Pages: 2151 - 2157
Accuracy of histological grades from intraoperative frozen-section diagnoses of soft-tissue tumors Shinji MiwaNorio YamamotoHiroyuki Tsuchiya Original Article 10 August 2020 Pages: 2158 - 2165
TERT promotor region rearrangements analyzed in high-risk neuroblastomas by FISH method and whole genome sequencing Masumi KawashimaYuka UedaEiso Hiyama Original Article 07 September 2020 Pages: 2166 - 2174
Mean platelet volume may not be a significant prognostic factor in patients with metastatic castration-resistant prostate cancer Cengiz BeyanEsin Beyan Letter to the Editor 16 July 2020 Pages: 2175 - 2176
Reply to Cengiz Beyan and Esin Beyan. Mean platelet volume may not be a significant prognostic factor in patients with metastatic castration-resistant prostate cancer. Int J Clin Oncol 97(2), 3–4, 2020 Wataru FukuokayaTakahiro KimuraShin Egawa Letter to the Editor 26 October 2020 Pages: 2177 - 2178